Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

864 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer.
Benedetti R, Dell'Aversana C, De Marchi T, Rotili D, Liu NQ, Novakovic B, Boccella S, Di Maro S, Cosconati S, Baldi A, Niméus E, Schultz J, Höglund U, Maione S, Papulino C, Chianese U, Iovino F, Federico A, Mai A, Stunnenberg HG, Nebbioso A, Altucci L. Benedetti R, et al. Among authors: baldi a. Cancers (Basel). 2019 Dec 16;11(12):2027. doi: 10.3390/cancers11122027. Cancers (Basel). 2019. PMID: 31888209 Free PMC article.
Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.
Spugnini EP, Cardillo I, Verdina A, Crispi S, Saviozzi S, Calogero R, Nebbioso A, Altucci L, Cortese G, Galati R, Chien J, Shridhar V, Vincenzi B, Citro G, Cognetti F, Sacchi A, Baldi A. Spugnini EP, et al. Among authors: baldi a. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6133-43. doi: 10.1158/1078-0432.CCR-06-1056. Clin Cancer Res. 2006. PMID: 17062690
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells.
Franci G, Casalino L, Petraglia F, Miceli M, Menafra R, Radic B, Tarallo V, Vitale M, Scarfò M, Pocsfalvi G, Baldi A, Ambrosino C, Zambrano N, Patriarca E, De Falco S, Minchiotti G, Stunnenberg HG, Altucci L. Franci G, et al. Among authors: baldi a. Biol Open. 2013 Aug 22;2(10):1070-7. doi: 10.1242/bio.20135587. eCollection 2013. Biol Open. 2013. PMID: 24167717 Free PMC article.
RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer.
Carafa V, Nebbioso A, Cuomo F, Rotili D, Cobellis G, Bontempo P, Baldi A, Spugnini EP, Citro G, Chambery A, Russo R, Ruvo M, Ciana P, Maravigna L, Shaik J, Radaelli E, De Antonellis P, Tarantino D, Pirolli A, Ragno R, Zollo M, Stunnenberg HG, Mai A, Altucci L. Carafa V, et al. Among authors: baldi a. Clin Cancer Res. 2018 Jun 15;24(12):2886-2900. doi: 10.1158/1078-0432.CCR-17-3081. Epub 2018 Mar 13. Clin Cancer Res. 2018. PMID: 29535128
Combined HAT/EZH2 modulation leads to cancer-selective cell death.
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-Megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L. Petraglia F, et al. Among authors: baldi a. Oncotarget. 2018 May 22;9(39):25630-25646. doi: 10.18632/oncotarget.25428. eCollection 2018 May 22. Oncotarget. 2018. PMID: 29876013 Free PMC article.
Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer.
Carafa V, Poziello A, Della Torre L, Giovannelli P, Di Donato M, Safadeh E, Yu Z, Baldi A, Castoria G, Tomaselli D, Mai A, Rotili D, Nebbioso A, Altucci L. Carafa V, et al. Among authors: baldi a. Int J Mol Sci. 2019 Nov 12;20(22):5654. doi: 10.3390/ijms20225654. Int J Mol Sci. 2019. PMID: 31726691 Free PMC article.
864 results